Gwyneth sits down with Mike Blue—CEO of HistoSonics—to explore histotripsy, a breakthrough noninvasive ultrasound technology designed to destroy tumors without surgery, chemotherapy, or radiation. He shares the 25-year journey behind the technology, the patients already benefiting from the FDA-cleared treatment for liver tumors, and how this approach could challenge decades of invasive cancer care—signaling a profound shift toward safer, more precise treatment.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
